Billions up for grabs as EU patent on AbbVie’s Humira expiresThe patent for Humira, the world’s bestselling drug, expires in Europe today – opening the door for a Share XBillions up for grabs as EU patent on AbbVie’s Humira expireshttps://pharmaphorum.com/news/billions-up-for-grabs-as-eu-patent-abbvies-humira-expires/
Sensyne’s gestational diabetes AI app launches on the NHSArtificial intelligence company Sensyne Health has launched a new app that helps women manage gestational diabetes, and five Share XSensyne’s gestational diabetes AI app launches on the NHShttps://pharmaphorum.com/news/sensynes-gestational-diabetes-ai-app-launches-on-the-nhs/
AZ to continue with investment freeze following ‘no deal’ BrexitAstraZeneca will keep manufacturing investments in Britain on hold if the UK’s negotiations with Brussels fail to provide Share XAZ to continue with investment freeze following ‘no deal’ Brexithttps://pharmaphorum.com/news/az-to-continue-with-investment-freeze-following-no-deal-brexit/
Living with LHON: Blindness doesn’t mean losing sight of your dreamsLosing your sight is every bookworm’s worst nightmare, but former English teacher Paula Morandi has not let her Share XLiving with LHON: Blindness doesn’t mean losing sight of your dreamshttps://pharmaphorum.com/disease-spotlight/living-with-lhon-blindness-doesnt-mean-losing-sight-of-your-dreams/
It’s time to get smart about blockchain in healthcareHealthcare data is everywhere and more is coming – data from wearables, data from Internet of Things devices, Share XIt’s time to get smart about blockchain in healthcarehttps://pharmaphorum.com/digital/its-time-to-get-smart-about-blockchain-in-healthcare/
Ahead of the curvePharma often criticises the NHS for failing to adopt the latest therapies, arguing that NICE’s technology appraisals can Share XAhead of the curvehttps://pharmaphorum.com/views-analysis-oncology/ahead-curve-car-t/
CAR-Ts – a new weapon in the fight against cancerCAR-T – or Chimeric Antigen Receptor T-cell therapies herald a new wave of therapies in cancer. CAR-T therapies Share XCAR-Ts – a new weapon in the fight against cancerhttps://pharmaphorum.com/views-and-analysis/car-ts-a-new-weapon-in-the-fight-against-cancer/
How to achieve digital success in pharma’s communicationsDemystifying what digital means, empowering people to ‘think digitally’ and acting with confidence are game changing factors for Share XHow to achieve digital success in pharma’s communicationshttps://pharmaphorum.com/views-analysis-digital/achieve-digital-success-pharma/
Future-proofing pharma with a multichannel approach to sales and marketingDeploying a multichannel approach to marketing, backed by the use of advanced analytics, could help pharma evolve and Share XFuture-proofing pharma with a multichannel approach to sales and marketinghttps://pharmaphorum.com/views-analysis-sales-marketing/multichannel-marketing-sales-pharma/
Realising the biotech promise: addressing the path to market Share XRealising the biotech promise: addressing the path to markethttps://pharmaphorum.com/market-access-2/addressing-the-path-to-market/
10/12/2018Digital therapeutics and healthcare innovation Share XDigital therapeutics and healthcare innovationhttps://pharmaphorum.com/debates-insight-digital/digital-therapeutics-and-healthcare-innovation/
How to make digital work in medtech Share XHow to make digital work in medtechhttps://pharmaphorum.com/webinars/webinars-on-demand/make-digital-work-medtech/
The changing face of pharmaceutical launchesThe industry has experienced a sustained period of change since its blockbuster heyday in the 1990s and continues Share XThe changing face of pharmaceutical launcheshttps://pharmaphorum.com/market-access-2/digital-transforming-pharmaceutical-launches/
Remote HCP engagement – still a struggle for life science companiesLife science companies are failing to achieve their full digital potential, particularly when it comes to the use Share XRemote HCP engagement – still a struggle for life science companieshttps://pharmaphorum.com/white-papers/remote-hcps-engagement-life-science/
Medical meetings and what HCPs wantThe healthcare professional (HCP) meeting landscape is evolving, but even as it adjusts to the demands of the Share XMedical meetings and what HCPs wanthttps://pharmaphorum.com/whitepapers/medical-meetings-and-what-hcps-want/
Raising the bar in liver cancer therapy Share XRaising the bar in liver cancer therapyhttps://pharmaphorum.com/oncology/insights-oncology/raising-bar-liver-cancer-therapy/
Eisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s success Share XEisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s successhttps://pharmaphorum.com/oncology/insights-oncology/eisais-emea-ceo-gary-hendler-lenvimas-success/
Part three: Oncology shaping the future of personalised healthcare Share XPart three: Oncology shaping the future of personalised healthcarehttps://pharmaphorum.com/video/part-three-oncology-shaping-future-personalised-healthcare/
An Interview with Alexander Zuern, Device Testing Manager, from Novartis Share XAn Interview with Alexander Zuern, Device Testing Manager, from Novartishttps://pharmaphorum.com/partner-content/an-interview-with-alexander-zuern-device-testing-manager-from-novartis/
Preliminary Attendee List Released for Orphan Drugs & Rare Diseases Conference Share XPreliminary Attendee List Released for Orphan Drugs & Rare Diseases Conferencehttps://pharmaphorum.com/partner-content/preliminary-attendee-list-released-for-orphan-drugs-rare-diseases-conference/
Spotlight sessions at the upcoming Lyophilization USA Conference Share XSpotlight sessions at the upcoming Lyophilization USA Conferencehttps://pharmaphorum.com/partner-content/spotlight-sessions-at-the-upcoming-lyophilization-usa-conference/
Exclusive Speaker Interview with Brent Cezairliyan for SMi’s Superbugs & Superdrugs USA Share XExclusive Speaker Interview with Brent Cezairliyan for SMi’s Superbugs & Superdrugs USAhttps://pharmaphorum.com/partner-content/exclusive-speaker-interview-with-brent-cezairliyan-for-smis-superbugs-superdrugs-usa/
Carina Schey, University of Groningen, Orphan Drugs & Rare Diseases Chair Invitation Share XCarina Schey, University of Groningen, Orphan Drugs & Rare Diseases Chair Invitationhttps://pharmaphorum.com/partner-content/carina-schey-university-of-groningen-orphan-drugs-rare-diseases-chair-invitation/
Corporate Communications chief of Astellas, Jo Taylor moves to Cello Health Communications Share XCorporate Communications chief of Astellas, Jo Taylor moves to Cello Health Communicationshttps://pharmaphorum.com/partner-content/corporate-communications-chief-of-astellas-jo-taylor-moves-to-cello-health-communications/
